Aethlon Medical (AEMD) Stock Price

Aethlon Medical Price

NASDAQ·CLOSED
2.83USD-0.10 (-3.47 %)
Market closed

Revenue at Aethlon Medical has contracted by 7.5% per year over the past 11 years to 574,245.00 USD. Aethlon Medical's net margin stands at -2,094.9%, up from -2,697.9% several years earlier. Analysts set a median price target of 12.62 USD, implying 346.0% above the current price. Of 7 analysts, 0 rate the stock a buy — an overall Sell consensus. The stock trades about 7% above its 52-week low.

Aethlon Medical stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Aethlon Medical over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Aethlon Medical stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Aethlon Medical's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Aethlon Medical Stock Price History
DateAethlon Medical Price
8/14/20262.83 USD
8/13/20262.93 USD
8/12/20262.93 USD
8/11/20263.18 USD
8/10/20263.08 USD
8/7/20263.15 USD
8/6/20263.02 USD
8/5/20263.25 USD
8/4/20263.52 USD
8/3/20263.35 USD
7/31/20263.30 USD
7/30/20262.85 USD
7/29/20262.64 USD
7/27/20262.91 USD
7/23/20263.00 USD
7/22/20262.95 USD
7/21/20263.05 USD
7/20/20263.00 USD
7/17/20263.25 USD
7/16/20263.35 USD
7/15/20263.45 USD
7/14/20263.45 USD
7/13/20263.35 USD
7/10/20263.55 USD
7/9/20263.47 USD
7/8/20263.65 USD
7/7/20263.65 USD
7/6/20263.50 USD
7/2/20263.55 USD
7/1/20263.80 USD
6/30/20264.12 USD
6/29/20264.24 USD
6/26/20264.35 USD
6/25/20264.46 USD
6/24/20266.10 USD
6/23/20266.80 USD
6/22/20267.30 USD
6/18/20269.45 USD
6/17/20269.55 USD
6/16/20269.65 USD
6/15/202610.00 USD
6/12/202610.10 USD
6/11/20269.50 USD
6/10/202610.10 USD
6/9/20269.70 USD
6/8/202610.15 USD
6/5/20269.55 USD
6/4/202610.65 USD
6/3/202610.50 USD
6/2/202611.05 USD
6/1/202612.05 USD
5/29/202611.05 USD
5/28/202614.70 USD
5/27/202615.35 USD
5/26/202612.25 USD
5/22/202611.00 USD
5/21/202610.50 USD
5/20/202610.35 USD
5/19/202610.25 USD
5/18/202610.20 USD
5/15/202610.50 USD
5/14/202610.70 USD
5/13/202610.70 USD
5/12/202610.95 USD
5/11/202610.95 USD
5/8/202611.25 USD
5/7/202611.50 USD
5/6/202611.90 USD
5/5/202611.80 USD
5/4/202612.00 USD
5/1/202611.50 USD
4/30/202611.15 USD
4/29/202610.65 USD
4/28/202610.75 USD
4/27/202610.85 USD
4/24/202611.00 USD
4/23/202611.25 USD
4/22/202611.45 USD
4/21/202611.75 USD
4/20/202611.95 USD
4/17/202611.70 USD
4/16/202611.60 USD
4/15/202611.60 USD
4/14/202611.55 USD
4/13/202611.00 USD
4/10/202610.85 USD
4/9/202611.10 USD
4/8/202611.15 USD
4/7/202610.45 USD
4/6/202610.65 USD
4/2/202610.60 USD
4/1/202610.75 USD
3/31/202610.95 USD
3/30/202610.55 USD
3/27/202610.75 USD
3/26/202611.35 USD
3/25/202611.60 USD
3/24/202610.80 USD
3/23/202611.50 USD
3/20/202610.80 USD
3/19/202611.05 USD
3/18/202611.20 USD
3/17/202611.10 USD
3/16/202610.55 USD
3/13/20269.75 USD
3/12/20268.65 USD
3/11/20268.25 USD
3/10/20268.45 USD
3/9/20268.70 USD
3/6/20268.50 USD
3/5/20268.70 USD
3/4/20269.15 USD
3/3/20268.85 USD
3/2/20269.35 USD
2/27/202610.05 USD
2/26/202610.00 USD
2/25/202610.15 USD
2/24/202610.02 USD
2/23/20269.90 USD
2/20/202610.05 USD
2/19/202610.20 USD
2/18/202610.45 USD
2/17/202610.60 USD
2/13/20269.80 USD
2/12/20269.90 USD
2/11/202610.45 USD
2/10/202611.00 USD
2/9/202611.15 USD
2/6/202611.15 USD
2/5/202610.70 USD
2/4/202611.20 USD
2/3/202611.65 USD
2/2/202612.00 USD
1/30/202612.50 USD
1/29/202612.75 USD
1/28/202613.25 USD
1/27/202614.00 USD
1/26/202615.05 USD
1/23/202616.40 USD
1/22/202615.25 USD
1/21/202613.80 USD
1/20/202613.50 USD
1/16/202614.60 USD
1/15/202613.53 USD
1/14/202613.08 USD
1/13/202612.85 USD
1/12/202611.90 USD
1/9/202611.90 USD
1/8/202612.30 USD
1/7/202613.65 USD
1/6/202614.20 USD
1/5/202613.75 USD
1/2/202614.10 USD
12/31/202513.85 USD
12/30/202513.45 USD
12/29/202512.40 USD
12/26/202512.80 USD
12/24/202512.45 USD
12/23/202513.30 USD
12/22/202514.40 USD
12/19/202514.30 USD
12/18/202514.15 USD
12/17/202514.25 USD
12/16/202514.70 USD
12/15/202515.25 USD
12/12/202517.00 USD
12/11/202517.00 USD
12/10/202518.60 USD
12/9/202517.45 USD
12/8/202519.70 USD
12/5/202518.50 USD
12/4/202520.15 USD
12/3/202518.50 USD
12/2/202524.18 USD
12/1/202521.05 USD
11/28/202522.20 USD
11/26/202521.55 USD
11/25/202520.30 USD
11/24/202520.55 USD
11/21/202518.15 USD
11/20/202517.85 USD
11/19/202518.85 USD
11/18/202521.00 USD
11/17/202520.25 USD
11/14/202524.75 USD
11/13/202523.70 USD
11/12/202521.00 USD
11/11/202521.70 USD
11/10/202521.75 USD
11/7/202520.95 USD
11/6/202521.30 USD
11/5/202522.55 USD
11/4/202522.60 USD
11/3/202524.60 USD
10/31/202526.30 USD
10/30/202527.15 USD
10/29/202528.75 USD
10/28/202527.15 USD
10/27/202526.00 USD
10/24/202526.95 USD
10/23/202526.20 USD
10/22/202524.25 USD
10/21/202525.10 USD
10/20/202527.55 USD
10/17/202527.00 USD
10/16/202527.63 USD
10/15/202534.96 USD
10/14/202535.00 USD
10/13/202533.75 USD
10/10/202534.50 USD
10/9/202536.84 USD
10/8/202537.88 USD
10/7/202536.42 USD
10/6/202538.67 USD
10/3/202539.50 USD
10/2/202539.97 USD
10/1/202536.45 USD
9/30/202537.44 USD
9/29/202538.50 USD
9/26/202537.50 USD
9/25/202538.48 USD
9/24/202538.89 USD
9/23/202538.98 USD
9/22/202538.95 USD
9/19/202536.50 USD
9/18/202539.00 USD
9/17/202537.70 USD
9/16/202537.76 USD
9/15/202536.56 USD
9/12/202538.50 USD
9/11/202539.50 USD
9/10/202532.56 USD
9/9/202532.50 USD
9/8/202533.70 USD
9/5/202536.00 USD
9/4/202536.71 USD
9/3/202536.50 USD
9/2/202544.34 USD
8/29/202550.56 USD
8/28/202555.16 USD
8/27/202542.99 USD
8/26/202541.91 USD
8/25/202537.85 USD
8/22/202542.99 USD
8/21/202559.21 USD
8/20/202530.01 USD
8/19/202530.55 USD
8/18/202531.63 USD
Access this data via the Eulerpool API
Get Free API Key

Aethlon Medical Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
574,245.00 USD
-11.90 M USD
-12.03 M USD
Jan 1, 2024
0.00 USD
-12.64 M USD
-12.21 M USD
Jan 1, 2025
0.00 USD
-9.34 M USD
-13.39 M USD
Jan 1, 2026
0.00 USD
-7.29 M USD
-7.15 M USD
Jan 1, 2027 (e)
0.00 USD
0.00 USD
-504,203.00 USD
Jan 1, 2028 (e)
0.00 USD
0.00 USD
-78,050.00 USD
Jan 1, 2030 (e)
8.87 M USD
1.77 M USD
-46,830.00 USD
Jan 1, 2031 (e)
24.03 M USD
4.81 M USD
-12,488.00 USD

Aethlon Medical Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 18, 2026, 11:55 AM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
2015201620172018201920202021202220232024202520262027e2028e2030e2031e
––––––––––––––8.0024.00
–––––––––––––––200.00
––––––––––––––-35,662.50-11,887.50
-0.95-1.41-3.09-2.49-2.85-2.85-2.85-2.85-2.85-2.85-2.85-2.85-2.85-2.85-2.85-2.85
-3.00-4.00-7.00-5.00-5.00-6.00-7.00-10.00-11.00-12.00-9.00-7.00––1.004.00
––––––––––––––12.5016.67
-6.00-4.00-7.00-5.00-6.00-6.00-7.00-10.00-12.00-12.00-13.00-7.00––––
-53.85-33.3375.00-28.5720.00–16.6742.8620.00–8.33-46.15––––
0.010.010.100.010.030.120.150.230.250.200.821.571.571.571.571.57
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Aethlon Medical generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Aethlon Medical retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Aethlon Medical's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Aethlon Medical has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Aethlon Medical's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Aethlon Medical stock margins

The Aethlon Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Aethlon Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Aethlon Medical.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
100.00 %
-3,542.53 %
-3,540.90 %
Jan 1, 2023
100.00 %
-2,072.05 %
-2,094.89 %
Jan 1, 2024
100.00 %
- %
- %
Jan 1, 2025
100.00 %
- %
- %
Jan 1, 2026
100.00 %
- %
- %
Jan 1, 2027 (e)
100.00 %
0.00 %
- %
Jan 1, 2028 (e)
100.00 %
0.00 %
- %
Jan 1, 2030 (e)
100.00 %
20.00 %
-0.53 %

Aethlon Medical Stock Revenue, EBIT, Earnings per Share

The Aethlon Medical earnings per share therefore indicates how much revenue Aethlon Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2022
1.28 USD
-45.41 USD
-45.39 USD
Jan 1, 2023
2.28 USD
-47.27 USD
-47.79 USD
Jan 1, 2024
0.00 USD
-62.04 USD
-59.93 USD
Jan 1, 2025
0.00 USD
-11.35 USD
-16.27 USD
Jan 1, 2026
0.00 USD
-4.64 USD
-4.55 USD
Jan 1, 2027 (e)
0.00 USD
0.00 USD
-3.23 USD
Jan 1, 2028 (e)
0.00 USD
0.00 USD
-0.50 USD
Jan 1, 2030 (e)
56.85 USD
1.13 USD
-0.30 USD

Aethlon Medical business model & stock analysis

Aethlon Medical Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Aethlon Medical Employees
Details
Date
Aethlon Medical Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees
Jan 1, 2026
- Employees

Aethlon Medical Segments

Aethlon Medical Revenue by Segment (1/2)

  • 3 Years

  • 5 Years

  • Max

Government Contract Revenue
Details
Date
Government Contract Revenue
Jan 1, 2019
229,625.00 USD

Aethlon Medical Revenue by Segment (2/2)

  • 3 Years

  • 5 Years

  • Max

Aethlon
ESI
Details
Date
Aethlon
ESI
Jan 1, 2019
229,625.00 USD
0.00 USD

Aethlon Medical Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Aethlon Medical historical P/E ratio, EBIT multiple, and P/S ratio

Aethlon Medical annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Aethlon Medical shares outstanding

The number of shares of Aethlon Medical was 823,100 in 2025. This indicates how many shares Aethlon Medical is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2022
229,500.00 Stocks
Jan 1, 2023
251,700.00 Stocks
Jan 1, 2024
203,700.00 Stocks
Jan 1, 2025
823,100.00 Stocks
Jan 1, 2026
1.57 M Stocks
Jan 1, 2027 (e)
1.57 M Stocks
Jan 1, 2028 (e)
1.57 M Stocks
Jan 1, 2030 (e)
1.57 M Stocks

Aethlon Medical stock splits

In Aethlon Medical's history, there have been no stock splits.

Current Aethlon Medical forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
0.00 % (0)
Hold
57.14 % (4)
Sell
42.86 % (3)
12M Price Target
12.62
Last Price
2.83
Currency
USD
12M Return Potential
346.02 %
LTM Return
0 %

Aethlon Medical Analyst Rating Actions

DateFirmActionRating
8/14/2025
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedNeutral
3/10/2025
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy
2/19/2025
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy
1/30/2025
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy
11/15/2024
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy
6/24/2024
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy
3/4/2024
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy
10/24/2023
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy
11/15/2022
Maxim Group
Maxim Group
DowngradeBuyHold
11/14/2022
Maxim Group
Maxim Group
DowngradeBuyHold

Aethlon Medical Earnings Calls

2025

Aethlon Medical Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/13/2026-0.80USD-0.00USD-2027 Q1
6/24/2026-2.06USD-0.00USD-2026 Q4
2/10/2026-2.47USD-0.00USD-2026 Q3
8/12/2025-0.88USD-0.00USD-2026 Q1
11/12/2024-0.20USD-0.00USD-2025 Q2
6/26/2024-1.20USD-0.00USD-2024 Q4
2/12/2024-1.39USD-0.00USD-2024 Q3
6/26/2023-0.23USD-14,717.00USD-2023 Q4
2/13/2023-0.22USD-71,050.00USD-2023 Q3
11/14/2022-0.22USD-70,542.00USD-2023 Q2

Aethlon Medical shareholder structure

% Name
14.44971%
Alumni Capital LP
Alumni Capital LP
11.85138%
Armistice Capital LLC
Armistice Capital LLC
9.84369%
Ikarian Capital LLC
Ikarian Capital LLC
2.87252%
Boothbay Fund Management, LLC
Boothbay Fund Management, LLC
1.34849%
Intracoastal Capital, L.L.C.
Intracoastal Capital, L.L.C.
0.86291%
Geode Capital Management, L.L.C.
Geode Capital Management, L.L.C.

Aethlon Medical Beneficial Ownership Filings (SEC 13D/G)

Shares Outstanding
-
StakeHolderFiling
11.50%
Sachs Investment Group, LLC
Sachs Investment Group, LLC
SEC ↗
9.90%
Ellen R. Weiner Family Revocable Trust
Ellen R. Weiner Family Revocable Trust
SEC ↗
7.70%
Mitchell P. Kopin
Mitchell P. Kopin
SEC ↗
6.40%
Chetan Shah, M.D.
Chetan Shah, M.D.
SEC ↗
6.10%
Utah Resources International, Inc.  (87-0273519)
Utah Resources International, Inc.  (87-0273519)
SEC ↗
6.10%
Tonaquint, Inc.  (87-0285597)
Tonaquint, Inc.  (87-0285597)
SEC ↗
6.10%
John M. Fife
John M. Fife
SEC ↗
6.10%
JFV Holdings, Inc.  (36-4426825)
JFV Holdings, Inc.  (36-4426825)
SEC ↗
6.10%
Inter-Mountain Capital I Corp.  (36-4075407)
Inter-Mountain Capital I Corp.  (36-4075407)
SEC ↗
5.70%
Adam Sackstein, M.D.
Adam Sackstein, M.D.
SEC ↗

Aethlon Medical Executives and Management Board

7 members · avg. age 66 · 29 % women

SL

Mr. Steven Larosa (58)

Chief Medical Officer

430,000.00 USD

Management

JF

Mr. James Frakes (68)

Chief Executive Officer, Chief Financial Officer, Director · since 2008

416,449.00 USD
SN

Ms. Susan Noonan

Managing Partner, Investor Relations · since 2021

–

Board of Directors

EB

Mr. Edward Broenniman (88)

Independent Chairman of the Board

147,500.00 USD
CS

Dr. Chetan Shah (55)

Independent Director

113,750.00 USD
AR

Ms. Angela Rossetti (71)

Independent Director

113,000.00 USD
NG

Mr. Nicolas Gikakis (58)

Independent Director

112,500.00 USD

Aethlon Medical Supply Chain

Aethlon Medical Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
2 companies
#NameTrend
1
Medica
Supplier·Health Care Equipment & Supplies·IT
-0.67
-0.54
-0.17
0.63
—
—
2
Merck
Supplier·Pharmaceuticals·DE
0.67
0.42
0.64
0.92
-0.12
0.27

Frequently asked questions about Aethlon Medical

Analysts currently set an average price target of 12.62 USD for the Aethlon Medical stock (median: 12.62 USD), implying +346.0 % versus the latest price. The consensus is based on 7 analyst ratings.

Aethlon Medical Analyst Price Targets 2026

7 analysts currently rate the Aethlon Medical stock: 0 recommend buying, 4 holding and 3 selling.

Aethlon Medical Analyst Price Targets 2026

Converted at the current exchange rate, the Aethlon Medical share trades at 2.44 EUR (2.83 USD).

The Aethlon Medical share (AEMD) is listed on 5 stock exchanges, including: NASDAQ (AEMD), Frankfurt (EJU.F), München (EJU.MU), Düsseldorf (EJU.DU), London (0A6R.L).

No history available for Aethlon Medical.

The revenue cannot currently be calculated for Aethlon Medical.

The profit of Aethlon Medical is -7.15 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Aethlon Medical is currently -0.62. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Aethlon Medical stock.

The P/S cannot be calculated for Aethlon Medical currently.

The Eulerpool Quality Score for Aethlon Medical is 2/10.

The ISIN of Aethlon Medical is US00808Y6041. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Aethlon Medical is A2PTUU. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Aethlon Medical is AEMD. The ticker symbol is used to trade Aethlon Medical shares on the stock exchange.

Aethlon Medical paid dividends every year for the past 0 years.

Aethlon Medical is assigned to the 'Health' sector.

The dividends of Aethlon Medical are distributed in USD.

All fundamentals and in-depth analysis of Aethlon Medical

Our stock analysis for Aethlon Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aethlon Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Aethlon Medical Stock
Aethlon Medical Revenue→
Aethlon Medical Stock
Aethlon Medical Net Income→
Aethlon Medical Stock
Aethlon Medical P/E→
Aethlon Medical Stock
Aethlon Medical P/S→
Aethlon Medical Stock
Aethlon Medical EBIT→
Aethlon Medical Stock
Aethlon Medical Dividend→
Aethlon Medical Stock
Aethlon Medical Directors Dealings→
Aethlon Medical Stock
Aethlon Medical Stocks→
Aethlon Medical Stock
Aethlon Medical Market capitalization→
Aethlon Medical Stock
Aethlon Medical Debt→
Aethlon Medical Stock
Aethlon Medical Liabilities→
Aethlon Medical Stock
Aethlon Medical Equity→
Aethlon Medical Stock
Aethlon Medical AAQS→
Aethlon Medical Stock
Aethlon Medical Employees→
Aethlon Medical Stock
Aethlon Medical ROE→
Aethlon Medical Stock
Aethlon Medical ROA→
Aethlon Medical Stock
Aethlon Medical ROCE→
Aethlon Medical Stock
Aethlon Medical News→
Aethlon Medical Stock
Aethlon Medical Analyst Price Targets→

Health Stocks

Aevis VictoriaAether IndustriesAFT PharmaceuticalsAesthetic Connect PCLAgape ATPAeolus PharmaceuticalsAgenusAelis FarmaAGFA GevaertAdynxxAgilent TechnologiesAdvicenneAll Stocks A–Z →